Title:
メチル（Ｒ）−７−［３−アミノ−４−（２，４，５−トリフルオロフェニル）−ブチリル］−３−トリフルオロメチル−５，６，７，８−テトラヒドロ−イミダゾ［１，５−α］ピラジン−１−カルボン酸塩
Document Type and Number:
Japanese Patent JP5756798
Kind Code:
B2
Abstract:
The pharmaceutically acceptable salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo [1,5-a]pyrazine-1-carboxylate, their preparation methods and their use for preparing anti-diabetic medicaments are disclosed.
Inventors:
Yuan Kai Hong
Ma Shutin
Ju Lin
Liu Houwen
Ma Shutin
Ju Lin
Liu Houwen
Application Number:
JP2012512185A
Publication Date:
July 29, 2015
Filing Date:
April 29, 2010
Export Citation:
Assignee:
JIANGSU HENGRUI MEDICINE CO.,LTD.
International Classes:
C07D487/04; A61K31/4985; A61P3/10
Domestic Patent References:
| JP2011508735A | ||||
| JP2013521223A | ||||
| JP2012519193A | ||||
| JP2006516268A | ||||
| JP2004536115A |
Foreign References:
| CN101417999A |
Attorney, Agent or Firm:
Xie Takamine